Newsroom
300 articles
Featured The Pharmacovigilance Risk Assessment Committee (PRAC) convened from September 25th to 28th, 2023, to review critical safety data. Among the significant outcomes was the decision to update the…
Featured The U.S. Food and Drug Administration (FDA) has taken a monumental step towards combating rare diseases. In a recent announcement, the agency disclosed the allocation of $27 million…
Introducing the Vaccine Monitoring Platform (VMP) research agenda The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) have introduced the Vaccine Monitoring…
In a recent development, the European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended against renewing the conditional marketing authorization for Blenrep (belantamab mafodotin), a medicine primarily…
Important Dear Healthcare Providers, We are writing to inform you of an important safety notice regarding Terumo Platelet Additive Solution+ (T-PAS+). Please carefully review the following information: Device Details:…
Featured In a critical advisory, healthcare professionals are being urged to exercise utmost caution when prescribing fluoroquinolone antibiotics (ciprofloxacin, delafloxacin, levofloxacin, moxifloxacin, ofloxacin). This class of antibiotics, while effective,…
Featured We want to bring to your attention an urgent recall affecting two specific batches of Lipocomb capsules, Lipocomb 10 mg/10 mg (batch PPA0465/460/001) and Lipocomb 20 mg/10 mg…
: In a move to ensure the safety and efficacy of weight management medications, the European Medicines Agency (EMA) has recently launched a comprehensive review of Mysimba (naltrexone/bupropion).…
Advancements in Device Safety Communication: The FDA’s Center for Devices and Radiological Health (CDRH) has released a comprehensive report to Congress on Postmarket Device Safety-Related Communications. This initiative…
Important We would like to bring to your attention an important recall notice regarding Ketofall 0.25 mg/ml Eye Drops Solution in single-dose containers. Background Information: The Health Products Regulatory…
We would like to bring to your attention an important recall notice regarding certain products manufactured by Sun Pharma UK Ltd. Specifically, this alert pertains to Gemcitabine 10mg/ml…
In a progressive move towards safeguarding the public’s health and interests, the UK government has officially commenced a consultation on unregulated cosmetic procedures. This significant step is aimed…
The European Medicines Agency (EMA) is taking proactive steps to safeguard the health of expectant mothers and their unborn children by recommending new measures to avoid exposure to…
Featured The Department of Health – Abu Dhabi (DoH) has closed a medical laboratory in the Emirate for violating regulations. The laboratory, which is located in Al Ain, was…
Important The UK government has announced a monumental commitment of £210 million to address one of the most pressing global health threats: antimicrobial resistance (AMR). The Challenge of Antimicrobial…
Talk to our experts and get tailored solutions to help you stay compliant and move forward with confidence.
Submit RFI/RFP
Request Consultation
Submit RFI/RFP